Kiniksa Pharmaceuticals, Ltd. (KNSA)
NASDAQ: KNSA · IEX Real-Time Price · USD
-0.34 (-1.69%)
May 17, 2024, 4:00 PM EDT - Market closed

Kiniksa Pharmaceuticals Statistics

Total Valuation

KNSA has a market cap or net worth of $1.40 billion. The enterprise value is $1.20 billion.

Market Cap 1.40B
Enterprise Value 1.20B

Important Dates

The last earnings date was Tuesday, April 23, 2024, before market open.

Earnings Date Apr 23, 2024
Ex-Dividend Date n/a

Share Statistics

KNSA has 70.94 million shares outstanding. The number of shares has increased by 1.26% in one year.

Shares Outstanding 70.94M
Shares Change (YoY) +1.26%
Shares Change (QoQ) -9.25%
Owned by Insiders (%) 4.22%
Owned by Institutions (%) 99.23%
Float n/a

Valuation Ratios

The trailing PE ratio is 164.75.

PE Ratio 164.75
Forward PE n/a
PS Ratio 4.65
Forward PS 3.36
PB Ratio 3.25
P/FCF Ratio 65.64
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings 138.85
EV / Sales 3.98
EV / EBIT n/a
EV / FCF 56.22

Financial Position

The company has a current ratio of 4.21, with a Debt / Equity ratio of 0.03.

Current Ratio 4.21
Quick Ratio 3.57
Debt / Equity 0.03
Debt / EBITDA n/a
Debt / FCF 0.57
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is 2.10% and return on invested capital (ROIC) is -6.88%.

Return on Equity (ROE) 2.10%
Return on Assets (ROA) 1.70%
Return on Capital (ROIC) -6.88%
Revenue Per Employee $1.02M
Profits Per Employee $29,125
Employee Count 297
Asset Turnover 0.60
Inventory Turnover 1.46


Income Tax -30.21M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +44.84% in the last 52 weeks. The beta is 0.32, so KNSA's price volatility has been lower than the market average.

Beta (1Y) 0.32
52-Week Price Change +44.84%
50-Day Moving Average 19.01
200-Day Moving Average 17.93
Relative Strength Index (RSI) 57.46
Average Volume (30 Days) 383,552

Short Selling Information

The latest short interest is 3.91 million, so 5.52% of the outstanding shares have been sold short.

Short Interest 3.91M
Short Previous Month 3.64M
Short % of Shares Out 5.52%
Short % of Float n/a
Short Ratio (days to cover) 10.11

Income Statement

In the last 12 months, KNSA had revenue of $301.77 million and earned $8.65 million in profits. Earnings per share was $0.12.

Revenue 301.77M
Gross Profit 264.82M
Operating Income -30.54M
Pretax Income -21.56M
Net Income 8.65M
EBITDA -16.36M
EBIT -21.56M
Earnings Per Share (EPS) $0.12
Full Income Statement

Balance Sheet

The company has $213.55 million in cash and $12.14 million in debt, giving a net cash position of $201.41 million or $2.84 per share.

Cash & Cash Equivalents 213.55M
Total Debt 12.14M
Net Cash 201.41M
Net Cash Per Share $2.84
Equity / Book Value 431.90M
Book Value Per Share 6.09
Working Capital 206.38M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $21.56 million and capital expenditures -$190,000, giving a free cash flow of $21.37 million.

Operating Cash Flow 21.56M
Capital Expenditures -190,000
Free Cash Flow 21.37M
FCF Per Share $0.30
Full Cash Flow Statement


Gross margin is 87.75%, with operating and profit margins of -10.12% and 2.87%.

Gross Margin 87.75%
Operating Margin -10.12%
Pretax Margin -7.15%
Profit Margin 2.87%
EBITDA Margin -5.42%
EBIT Margin -7.15%
FCF Margin 7.08%

Dividends & Yields

KNSA does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -1.26%
Shareholder Yield -1.26%
Earnings Yield 0.62%
FCF Yield 1.52%
Dividend Details

Analyst Forecast

The average price target for KNSA is $30.20, which is 52.76% higher than the current price. The consensus rating is "Strong Buy".

Price Target $30.20
Price Target Difference 52.76%
Analyst Consensus Strong Buy
Analyst Count 5
Revenue Growth Forecast (5Y) 20.94%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a


KNSA has an Altman Z-Score of 9.17 and a Piotroski F-Score of 4.

Altman Z-Score 9.17
Piotroski F-Score 4